News | Quality Assurance (QA) | September 16, 2019

Company will highlight new tools for workflow automation and emergent techniques

Sun Nuclear Presents Portfolio of Independent Radiotherapy QA Solutions at ASTRO 2019

The PlanCheck module now part of SunCheck, automates plan quality checks, validates treatment plans against requirements, and automatically assesses plan performance versus intent.


September 16, 2019 — At the 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting, running Sept. 15-18 in Chicago, Sun Nuclear Corp. will present novel advancements in radiation oncology quality management.

For the SunCheck Quality Management Platform, Sun Nuclear introduces PlanCheck. This new module within the SunCheck Patient workflow automates plan quality checks, validates treatment plans against requirements, and automatically assesses plan performance versus intent. At ASTRO 2019, Sun Nuclear will also highlight SunCheck's expanded direct device integration, plus support for Varian Halcyon System secondary dose calculations, pre-treatment quality assurance (QA) and in-vivo monitoring.

Sun Nuclear will also introduce new Precision Laser Systems for positron emission tomography/computed tomography (PET/CT) simulation, magnetic resonance (MR) simulation, MR-guided radiotherapy (RT) and linear accelerator (linac)-based RT. Redesigned to better fit clinical workflows, CT SIM+ and MICRO+ laser systems offer high precision and accuracy at the patient, with what the company calls unmatched reliability, laser line definition and laser line length. Compatible with all major third-party systems, CT SIM+ software provides automation for enhanced patient focus.  

Beyond workflow automation support, Sun Nuclear enables adoption of emergent treatment techniques, including stereotactic radiosurgery (SRS) and MR-guided radiation therapy (MRgRT).

Enhancing the Sun Nuclear SRS QA portfolio is the introduction of the MultiMet-WL Cube. The device quantifies the margin of error for off-axis SRS targets, measuring error margins for single-isocenter multiple metastases treatments. Further supporting SRS programs are advancements with SRS MapCheck, including support for the Accuray CyberKnife System and vertex fields, including HyperArc. 

Sun Nuclear addresses the challenges of MRgRT with a suite of solutions, including ArcCheck-MR and IC Profiler-MR. Available soon and on display at ASTRO, Daily QA-MR will become the first commercially available daily QA system for MR-linacs.

For more information: www.sunnuclear.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Radiation Therapy

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...

Time July 22, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Subscribe Now